Navigation Links
AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease

PORTLAND, Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, Inc. (Nasdaq:AVII) announced today that its partner Cook Medical has completed target patient enrollment and released six-month follow-up data from a Phase II clinical trial known as Appraisal. The trial, currently being held in Germany, was designed to study the effect of the Neugene(R) antisense drug Resten-MP(TM), when used in conjunction with the placement of one or more bare metal stents, in the prevention of cardiovascular restenosis, the narrowing of an artery following a cardiac procedure such as angioplasty.

"We are pleased with the progress our partner Cook Medical has made with our NEUGENE in this trial," said K. Michael Forrest, interim chief executive officer of AVI. "We look forward to continuing our collaboration with Cook Medical as they work to commercialize our technology in the cardiology market."

Cook's release may be viewed on AVI's website at www.avibio.com.

About AVI BioPharma

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy. More information about AVI is available on the company's Web site at http://www.avibio.com.

About Cook Medical

Cook Medical was the first company to introduce interventional devices in the United States. Today, the company participates in all gl
'"/>




Page: 1 2

Related medicine technology :

1. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. GenoLogics Announces Bioinformatics Partnership with Illumina
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

Post Your Comments:
(Date:11/6/2009)...RNewswire-FirstCall/ -- Roper Industries, Inc. (...definitive agreement to acquire Verathon, Inc., a ...The Verathon Board of Directors has approved the t... regulatory approvals and closing conditions, incl...e closing to be completed in early December. ,...
(Date:11/6/2009)... Facet Solutions, Inc. announced to...us Orthopedics. The acquisition creates an undispu...llectual property and clinical experience in poste...nts suffering from lumbar spinal stenosis," stated.... "This consolidation further strengthens Facet S...
(Date:11/6/2009)...6 With his proposed health care re...ts on cutting name-brand prescription drug costs b...he "Part D" coverage gap, universally known as the...tial cost-cutting and feel it,s a promising start ...ul lobbyists want a revised program that completel...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Facet Solutions Acquires Archus Orthopedics 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 1Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 2Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 3Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 4Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 5Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 1Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 3Economists to Declare Health Reform Key to Recovery 3B New Reports Detail Employer Health Mandate 48868 1
...vival increase in advanced non-small cell, lung ca...th paclitaxel and ci...ings include reductions in chemotherapy...and TOKYO, March 18 BioNumerik,Pharmaceuticals, I...d.,("ASKA") today announced the results of a Phase...
...rominent peer-reviewed journal highlights,findings... infection, EVANSTON, Ill., March 17 Universal h...hylococcus aureus (MRSA) using a,rapid molecular d...ing MRSA,disease, according to research published ...anston Northwestern Healthcare (ENH) researchers. ...
Other Medicine Technology:BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 2BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 3BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 4BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 5Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 2Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 3
(Date:11/7/2009)...ewswire/ -- Speaker Nancy Pelosi spoke on the Hou...able Health Care for America Act. The House will ...the Speaker,s remarks. ,, "Madam Speaker, toda...ation and for American families. For nearly a cen...phy -- as far back as Teddy Roosevelt -- have call...
(Date:11/7/2009)...ng this a "defining moment" for the American Medic...ohack, M.D., today addressed medical students and ...alty societies at the opening of the AMA,s semi-an...form will top the agenda. ,, (Logo: http://ww..., "Over the next 72 hours, this AMA House of Del...
(Date:11/7/2009)...wire/ -- The U.S. bishops November 7 urged members...tupak-Ellsworth Amendment to the health care refor...mper-Lipinski-Smith Amendment will keep in place c...nce protections in the Affordable Health Care for ...ter was signed by Cardinal Justin Rigali, chair of...
(Date:11/7/2009)... rebel, expert says , , SATURDAY, Nov. 7 (... badly if their parents expect them to, a new U.S....simply being realistic might actually contribute t... psychology professor at Wake Forest University an...s release. "Negative expectations on the part of b...
(Date:11/7/2009)...tox’ or ‘Boytox’, the new trend ... jab ‘Breastox’ – or breast boto...e, can reduce the appearance of wrinkles and lift ...ving smoother, younger-looking skin. , ...m, the UK’s largest group of cosmetic surge...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:UK Boobs Get a Boost with 'Breastox' 2
... The following release was issued today by the Na...s after federal vaccine court ruled against three ...children, Huffington Post writers Robert F Kenne...ek, Banks, parents were awarded a lump sum of more...
...worker at a paper-recycling plant, fell through a ...as he was preparing to inspect a steam valve. Supe... degrees Fahrenheit, enveloped his legs instantly,...ft with first-, second- and third-degree burns on ...
...6 Most people accustomed to working within a mana... question the quality of their care or the cost of...charge until after a surgery when they get the bil...ings accounts (HSA) are growing in popularity. Yo...
...eb. 26 On Monday, March 2, the advertising and ...y to become "The Healthiest Company in Green Bay."...the area to beat them at that goal. , , The 30-pe...Company in Green Bay," is based on a list of key h...
... of education and cultural competence as keys to s...emy of Orthopaedic Surgeons ( http://www.aaos.o... has spent the majority of his life encouraging th...today with the Academy,s Diversity Award at its 20...
...ns aid orthopaedic surgeons in treating this commo...itis (OA) ( http://www.orthoinfo.org/topic.cfm?to...tis. It can affect any joint in the body particul... of the American Academy of Orthopaedic Surgeons ...
Other Medicine News:Health News:On the Heels of Court Ruling Denying Autism-Vaccine Link, U.S. Federal Court Declares MMR Vaccine Caused Autism in a Young Boy 2Health News:Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching 2Health News:Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 2Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 4Health News:Arketype to Become Green Bay's Healthiest Company in One Year -- Wanna Bet? 2Health News:Arketype to Become Green Bay's Healthiest Company in One Year -- Wanna Bet? 3Health News:Ramon L. Jimenez, MD: A Diverse Life 2Health News:Ramon L. Jimenez, MD: A Diverse Life 3Health News:An Orthopaedic Roadmap for Osteoarthritis of the Knee 2Health News:An Orthopaedic Roadmap for Osteoarthritis of the Knee 3
...IFICATIONS Form: Granular, free-flowing powder EEO...#37;): less than or equal to 35C Remelt Point (3&#...7;): greater than or equal to 300 gm/cm 2 Moistur... equal to 0.10% DNase: Passes test RNase: Pass...
...804; 500 mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg .../kg Co ≤ 5 mg/kg Cr ≤ 5 mg/kg Cu Ͱ...Mg ≤ 50 mg/kg Mn ≤ 5 mg/kg Na ≤ ...n ≤ 5 mg/kg Special grade: for molecular bio...
...804; 500 mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg ...g/kg Co ≤ 5 mg/kg Cr ≤ 10 mg/kg Cu ...g Mg ≤ 5 mg/kg Mn ≤ 5 mg/kg Na ≤...Zn ≤ 5 mg/kg Special grade: for molecular bi...
Agarose, high purity, Molecular Biology Grade
Medicine Products: